Carrier‐Free Nanoassembly of Curcumin–Erlotinib Conjugate for Cancer Targeted Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carrier‐Free Nanoassembly of Curcumin–Erlotinib Conjugate for Cancer Targeted Therapy

Published:2020-09-06 Issue:19 Volume:9 Page:2001128
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Cheng Chen¹,Sui Binglin¹,Wang Mingming¹,Hu Xiangxiang¹,Shi Shanshan¹,Xu Peisheng¹^ORCID

Affiliation:

1. Department of Discovery and Biomedical Sciences College of Pharmacy University of South Carolina 715 Sumter Columbia SC 29208 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202001128

Reference41 articles.

1. Cancer statistics, 2019

2. Recent progress in pancreatic cancer

3. A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer

4. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

5. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Nanomedicine-Based Dry Powder Inhalation Formulation Co-Loaded with Erlotinib and Curcumin for Treatment of Non-Small Cell Lung Cancer;Nano LIFE;2024-07-31

2. Enhancing targeted cancer therapy through multiple drug delivery by silk peptide nanoparticles;Nano Select;2024-02-27

3. Supramolecular interaction in the action of drug delivery systems;Chemical Science;2024

4. Different combination therapies pertaining to pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

5. Curcumin-drug conjugate-based drug delivery as cancer therapeutics;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3